Navigation Links
Clinical Tests Demonstrate Long-Term Effectiveness of Oral Glutathione Supplements - Kyowa Study
Date:5/7/2013

NEW YORK, May 7, 2013 /PRNewswire-iReach/ -- Glutathione is the body's master antioxidant involved in protecting cells and tissues from oxidants and a large variety of other toxins and insults. Debate over whether orally administered glutathione could be effective at enhancing glutathione levels in cells and tissues has simmered for years. Now, a Penn State College of Medicine study shows oral supplementation is effective in increasing the body's stores of this vital nutrient.

(Logo: http://photos.prnewswire.com/prnh/20130507/CG09410)

The study of 54 healthy adults revealed that glutathione (GSH) levels of those taking 1000mg of Setria® Glutathione a day for six months increased 30%-35% in many compartments including red blood cells, lymphocytes and plasma, and of those taking 250mg of Setria® Glutathione increased in whole blood. And as glutathione stores increased in the high-dose group, so did the function of natural killer (NK) cells, a marker for increased immune defense, said John P. Richie, Jr. , Ph.D., professor of Public Health Sciences and Pharmacology at Penn State College of Medicine.

"A battery of immune function markers was examined after three months of glutathione supplementation and NK cytotoxicity was enhanced more than two-fold for participants taking 1000mg daily doses," Dr. Richie said. "We believe GSH supplementation may represent an effective intervention strategy for disease prevention and may enhance immune function."

There is a school of thought that contends that glutathione is broken down in the stomach and intestine and effective increases of GSH must come via intravenous administration. However, previous animal studies showed that orally administered glutathione is bioavailable and will enhance tissue GSH levels, Dr. Richie said.

"Our research showed that in most cases increases were dose and time dependent, and levels returned to baseline after a one-month washout," he said. "By taking daily GSH supplements, we believe efficacious levels will persist, and that oral intake is an effective means of chronically enhancing the body's stores."

Dr. Richie presented the study findings – "Enhanced Glutathione Levels in Blood and Buccal Cells by Oral Glutathione Supplementation" – at the Experimental Biology 2013 conference in Boston on April 22. The study was a joint effort of the Pennsylvania Department of Public Health Sciences, the Penn State Hershey Cancer Institute, and the Penn State College of Medicine.

About John P. Richie , Ph.D.

Dr. Richie is professor, Public Health Sciences and Pharmacology, at Penn State College of Medicine, State College, Penn. He has researched has researched glutathione for more than 30 years, including its role in protecting against oxidative damage during aging and the development of cancer at numerous sites in the body. Dr. Richie's research focuses on the factors that regulate glutathione, oxidative stress and cancer risk in individuals and in various populations.

About Setria

Setria® Glutathione, manufactured by Kyowa Hakko USA, is a clinically studied, absorbable form of glutathione that can help replenish the body's reserves that may be depleted as a result of poor lifestyle choices, stress, or natural aging. Called the "master antioxidant," benefits of glutathione include protecting cells in the body from the damaging effects of oxidative stress and toxins. Setria Glutathione is manufactured through a patented fermentation and patent pending for increasing NK natural killer (NK) cells, is pure, vegetarian and allergen-free. For more information about Setria GSH, please visit: http://www.setriaglutathione.com.

About Kyowa Hakko USA

Kyowa Hakko USA is the North American sales office for Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa is the maker of branded ingredients including Cognizin® Citicoline, Lumistor® L-Hydroxyproline, Pantesin® Pantethine, Setria® Glutathione, as well as Sustamine™ L-Alanyl-L-Glutamine. For more information, visit http://www.kyowa-usa.com.

Media Contact:

Dave Clifton , Setria® Glutathione, 385-222-7035, dave@brandhive.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Setria
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer
2. Federal Government Organization achieves cleaner and faster Clinical Study Data using Tablet PCs from TabletKiosk
3. AACR news: Paragazole excels in preclinical models of triple-negative breast cancer
4. NYSCF scientists develop new protocol to ready induced pluripotent stem cell clinical application
5. ACMG releases report on incidental findings in clinical exome and genome sequencing
6. IUPUI stem cell research could expand clinical use of regenerative human cells
7. New AAN/ALS Association Clinical Fellow Will Pursue Immune Biomarkers
8. Preclinical study shows potential of new technologies to detect response to cancer therapy earlier
9. Cleveland Clinic develops clinical screening program for no.1 genetic cause of colon cancer
10. Major clinical trial finds no link between genetic risk factors and 2 top wet AMD treatments
11. Hot topics in translational bone research at IOF-ESCEO 3rd Pre-Clinical Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
(Date:3/31/2016)... , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange is ... users of its soon to be launched online site ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders ... of DNA technology to an industry that is notorious ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... 27, 2016 , ... Newly created 4Sight Medical Solutions ... the healthcare market. The company's primary focus is on new product introductions, to ... that are necessary to help companies efficiently bring their products to market. , ...
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
Breaking Biology Technology: